Clinical trials: Hyperprolactinaemia
HELICOBACTER PYLORI INFECTIONS, Hyperprolactinaemia
Impact of Helicobacter Pylori Infection on Prolactin Levels in Reproductive-Age Women to Determine Whether H. Pylori Infection is Associated with Elevated Prolactin Levels and Assess the Clinical Implications
The research is a cross-sectional observational study conducted at Assiut University Hospital. It will involve 75 women aged 18-45 with confirmed H. pylori infection. The study will measure serum prolactin levels and H.
- Trial name
- NCT06870773
- Volunteers
- 75 people
- Sponsor
- Assiut University
Pituitary Disease, Pituitary Incidentaloma
Seoul National University Pituitary Disease Cohort Study
The purpose of this study is to investigate the treatment and natural history of pituitary disease. We have a longstanding interest in pituitary disease including acromegaly, central diabetes insipidus, and nonfunctioning…
- Conditions
- Pituitary Disease, Pituitary Incidentaloma, Acromegaly, Central Diabetes Insipidus
- Trial name
- SNU-PIT (NCT03474601)
- Testing
- Dynamic hormone study and Magnetic resonance imaging
- Where
- South Korea
- Volunteers
- 1,600 people
- Sponsor
- Seoul National University Hospital
Schizophrenia, Schizophrenic Disorder
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
The investigators hypothesize that Peony-Glycyrrhiza Decoction (PGD) adjunctive therapy could reduce the incidence of prolactin (PRL)-related adverse events in patients with schizophrenia and suppress antipsychotic-induced…
- Conditions
- Schizophrenia, Schizophrenic Disorder, Hyperprolactinemia, Hyperprolactinaemia
- Trial name
- PGD-RCT (NCT01852331)
- Testing
- PGD granules
- Where
- 4 sites in China
- Volunteers
- 103 people
- Sponsor
- The University of Hong Kong
APS-related Hyperprolactinaemia, Schizophrenia
Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine
Hyperprolactinaemia is a common side effect of some antipsychotics (APS), including some atypicals. Clinical consequences of hyperprolactinaemia are broad including amenorrhea, galactorrhea, tender breasts, gynecomastia and…
- Conditions
- APS-related Hyperprolactinaemia, Schizophrenia, Bipolar Disorder
- Trial name
- NCT00952757
- Where
- 6 sites in Spain
- Volunteers
- 35 people
- Sponsor
- Investigaciones Médicas Montejo S.L.